Cargando…

Murine Models of Steroid Refractory Graft-versus-Host Disease

Corticosteroids are the first line therapy for acute graft-versus-host disease (GVHD). However, the outcome of steroid refractory GVHD (SR-GVHD) is poor due to a lack of effective treatments. The development of therapies for SR-GVHD is limited by an incomplete understanding of its pathophysiology pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Toubai, Tomomi, Rossi, Corinne, Tawara, Isao, Liu, Chen, Zajac, Cynthia, Oravecz-Wilson, Katherine, Peltier, Daniel, Sun, Yaping, Fujiwara, Hideaki, Wu, Shin-Rong, Riwes, Mary, Henig, Israel, Kim, Stephanie, Reddy, Pavan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6102256/ https://www.ncbi.nlm.nih.gov/pubmed/30127532 http://dx.doi.org/10.1038/s41598-018-30814-x

Ejemplares similares

Microbial metabolite sensor GPR43 controls severity of experimental GVHD
por: Fujiwara, Hideaki, et al.
Publicado: (2018)

The Role of Dendritic Cells in Graft-Versus-Tumor Effect
por: Toubai, Tomomi, et al.
Publicado: (2014)

SNARE protein SEC22B regulates early embryonic development
por: Wu, Shin-Rong J., et al.
Publicado: (2019)

Danger Signals and Graft-versus-host Disease: Current Understanding and Future Perspectives
por: Toubai, Tomomi, et al.
Publicado: (2016)

Ikaros deficiency in host hematopoietic cells separates GVL from GVHD after experimental allogeneic hematopoietic cell transplantation
por: Toubai, Tomomi, et al.
Publicado: (2015)

Gut microbiome derived metabolites modulate intestinal epithelial cell damage and mitigate Graft-versus-Host Disease
por: Mathewson, Nathan D., et al.
Publicado: (2016)

Differential susceptibility of C57BL/6NCr and B6.Cg-Ptprc(a )mice to commensal bacteria after whole body irradiation in translational bone marrow transplant studies
por: Duran-Struuck, Raimon, et al.
Publicado: (2008)

Editorial on Translational Research in Graft-Versus-Host Disease (GVHD) and Graft-Versus-Tumor (GVT) Effect After Allogeneic Hematopoietic Cell Transplantation
por: Czech, Marie, et al.
Publicado: (2022)

Allogeneic T cells cause acute renal injury after hematopoietic cell transplantation
por: Miyata, Masahiro, et al.
Publicado: (2023)

Intramesenteric Steroid Treatment for Steroid- Refractory Gastrointestinal Graft Versus Host Disease
por: Bilgin, Aynur Uğur, et al.
Publicado: (2012)

A Pipeline for Faecal Host DNA Analysis by Absolute Quantification of LINE-1 and Mitochondrial Genomic Elements Using ddPCR
por: He, Kuang, et al.
Publicado: (2019)

Recent Advances of Acute Kidney Injury in Hematopoietic Cell Transplantation
por: Miyata, Masahiro, et al.
Publicado: (2022)

Rearrangement of T Cell genome architecture regulates GVHD
por: Sun, Yaping, et al.
Publicado: (2022)

Aging is associated with increased regulatory T-cell function
por: Garg, Sanjay K, et al.
Publicado: (2014)

Experimental Pharmaceuticals for Steroid-Refractory Acute Graft-versus-Host Disease
por: Abedin, Sameem, et al.
Publicado: (2020)

Research progress in refractory sudden hearing loss: steroid therapy
por: Liu, Ya, et al.
Publicado: (2020)

Exocrine Pancreatic Insufficiency Possibly Related to Atypical Chronic Graft-versus-Host Disease
por: Hosokawa, Yuka, et al.
Publicado: (2023)

Ruxolitinib in steroid refractory graft-vs.-host disease: a case report
por: Maffini, Enrico, et al.
Publicado: (2016)

Treatment and unmet needs in steroid-refractory acute graft-versus-host disease
por: Malard, Florent, et al.
Publicado: (2020)

Fecal microbiota transplantation for steroid-refractory gastrointestinal graft-versus-host disease
por: Kim, Hyun Min, et al.
Publicado: (2023)

Late Onset and Protracted Course of Steroid Refractory Chronic Graft-versus-Host Disease
por: Gunes, Gursel, et al.
Publicado: (2015)

Combination of bortezomib plus ruxolitinib in steroid-refractory chronic graft-versus-host disease
por: Kaloyannidis, Panayotis, et al.
Publicado: (2018)

Steroid-refractory chronic graft-versus-host disease: treatment options and patient management
por: Wolff, Daniel, et al.
Publicado: (2021)

Type 1 interferon to prevent leukemia relapse after allogeneic transplantation
por: Magenau, John M., et al.
Publicado: (2021)

Etanercept for steroid-refractory acute graft-versus-host disease: A single center experience
por: De Jong, Cornelis N., et al.
Publicado: (2017)

Efficacy and safety of ruxolitinib in steroid-refractory graft-versus-host disease: A meta-analysis
por: Fan, Shuang, et al.
Publicado: (2022)

Umbilical Cord Mesenchymal Stromal Cells for Steroid-Refractory Acute Graft-versus-Host Disease
por: Donadel, Camila Derminio, et al.
Publicado: (2023)

Prognostic value of blood biomarkers in steroid-refractory or steroid-dependent acute graft-versus-host disease: a REACH2 analysis
por: Socié, Gerard, et al.
Publicado: (2023)

Adjunctive Dietary Therapy Is Associated With Improved Gastrointestinal Symptoms in Steroid-Refractory Gastrointestinal Graft-Versus-Host Disease: A Case Series
por: Kaenkumchorn, Tanyaporn, et al.
Publicado: (2022)

Steroid Response in Refractory Asthmatics
por: Jang, An-Soo
Publicado: (2012)

Non-Coding RNA Mediated Regulation of Allogeneic T Cell Responses After Hematopoietic Transplantation
por: Peltier, Daniel, et al.
Publicado: (2018)

Inflammatory Cytokine Inhibition with Combination Daclizumab and Infliximab for Steroid Refractory Acute Graft-Versus-Host Disease
por: Rager, Alison, et al.
Publicado: (2010)

Efficiency and Toxicity of Ruxolitinib as a Salvage Treatment for Steroid-Refractory Chronic Graft-Versus-Host Disease
por: Wang, Dong, et al.
Publicado: (2021)

Extracorporeal photopheresis in acute and chronic steroid‑refractory graft-versus-host disease: an evolving treatment landscape
por: Greinix, Hildegard T., et al.
Publicado: (2022)

Economic burden of acute steroid-refractory graft-versus-host disease in commercially insured pediatric patients
por: Grabner, Michael, et al.
Publicado: (2021)

Hematopoietic Stem Cell Transplantation—50 Years of Evolution and Future Perspectives
por: Henig, Israel, et al.
Publicado: (2014)

Etanercept for steroid-refractory acute graft versus host disease following allogeneic hematopoietic stem cell transplantation
por: Park, Joo Han, et al.
Publicado: (2014)

2844. Butyrogenic Bacteria After Acute Graft vs. Host Disease Associate with the Development of Steroid Refractory GVHD
por: Golob, Jonathan L, et al.
Publicado: (2019)

Meta-Analysis of Interleukin-2 Receptor Antagonists as the Treatment for Steroid-Refractory Acute Graft-Versus-Host Disease
por: Shen, Meng-Zhu, et al.
Publicado: (2021)

Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease Using Commercial Mesenchymal Stem Cell Products
por: Murata, Makoto, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_rbgo4r9k8bnmfioocpdrmr1och